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Summary
Introduction: The epidemiology and the prognosis of asymptomatic moyamoya arteriopathy is
virtually unknown, mainly in white western population, while symptomatic moyamoya arte-
riopathy is a more known disease, both in children and in adult people. We are presenting a
single centre case series of six asymptomatic adult people with a neurosonological (Transcranial
Colour Coded Sonography — TCCS) suspicion of this type of cerebral arteriopathy, conﬁrmed by
Digital Subtraction Angiography (DSA).
Patients and methods: During a time period of three years we collected a series of six patients
(5 female and 1 male, mean age 29.16 + 8.45 years) with a neurosonological suspicion and a
neuroradiological diagnostic conﬁrmation of moyamoya type arteriopathy. All patients under-
went TCCS, brain magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA)
and DSA, besides the differential diagnosis of immunological or infectious etiology. The mean
follow-up was 1.8 years.
Results and discussion: All patients but one had a bilateral internal carotid artery (ICA) stenosis
at terminus and M1 middle cerebral artery (MCA) multiple stenoses. There is only one young
patient with an atypical unilateral pathway and narrowing of extracranial ICA with prominent
posterior cerebral artery (PCA) compensation. No clinical events occurred during the follow-up
and also brain MRI failed to ﬁnd new ischemic lesions, compared with the baseline examination.
Conclusions: Asymptomatic cerebral moyamoya arteriopathy is an infrequent but underesti-
mated condition in young white
deﬁne the natural course and pr
© 2012 Elsevier GmbH.
Abbreviations: DSA, Digital Subtraction Angiography; ECA, external car
artery; MRI, magnetic resonance imaging; MRA, magnetic resonance ang
Color Coded Sonography; TCD, TransCranial Doppler.
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in the follow up examinations and no patients reported focal58
ntroduction
oyamoya syndrome is a cerebrovascular disease that is
ssociated to a predisposition to stroke because of the pres-
nce of multiple progressive stenosis of the intracranial ICAs
nd their proximal branches. It is a distinguishing feature of
he disease the compensatory development of collateral cir-
ulation, determining the growth of a widespread network
f small vessels at the terminus of the ICA, on the cortical
urface, leptomeninges, and anastomotic branches of the
CA. The moyamoya syndrome includes patients with the
haracteristic moyamoya vasculopathy and well recognized
ssociated conditions, whereas moyamoya disease concerns
atients without known associated risk factors. The pathog-
omonic arteriographic ﬁndings are bilateral in moyamoya
isease, with a variable severity between sides. Unilateral
ndings are indicative of the moyamoya syndrome, even
ithout other associated risk factors [1].
It is more frequent in Asian populations and in children,
ainly in Japan, where it is themost common pediatric cere-
rovascular disease with a prevalence of about 3 cases per
00,000 children [2], but an adult form is also known and few
ases are described in white population. In Europe the inci-
ence of moyamoya among all ages is about 1/10th of that
bserved in Japan [3]. Therefore several data about the nat-
ral history of moyamoya disease concern Asian children [1].
he disease tends to be progressive, both in children and in
dult patients. The progression of the vascular involvement
sually means the increasing severity of stenosis to occlu-
ion of large intracranial arteries and the increasing number
f involved vessel segments, with a parallel development
f the collateral circulation. It is believed that the rate
f disease progression is high, even among asymptomatic
atients, and that medical therapy alone is not sufﬁcient to
top or slow it [4]. Current estimation is similar to the pre-
ious one that up to two thirds of patients with moyamoya
ave symptomatic progression over a 5-year period, and the
utcome is reported poor without treatment [4—6].
The natural course of the moyamoya disease in European
dult asymptomatic people is not so clear in the literature,
ecause of the small sample of the available studies, and
lso in neurosurgical studies the subgroup of asymptomatic
eople is not numerous. Therefore it is not automatically
ight that in this subpopulation the outcome of surgically
ntreated patients is poor.
Therefore several data are lacking for asymptomatic vs
ymptomatic patients, European vs Asian patients and adults
s children patients. The lesser-known group concerns the
symptomatic European adult patient. We are presenting a
ingle center case series of 6 European adult people with
symptomatic moyamoya disease, suspected through TCCS
nd conﬁrmed by DSA, followed-up in medical treatment.
aterials and methods
uring a time period of three years we collected a
eries of six patients (5 female and 1 male, mean
ge 29.16 + 8.45 years) with a neurosonological suspi-
ion and a neuroradiological diagnostic conﬁrmation of
oyamoya type arteriopathy. All patients underwent to
eurosonological examination for episodic not related symp-
oms, like dizziness, or for a screening purpose in a
n
t
sG. Malferrari et al.
amily history of cerebrovascular atherosclerotic accidents.
esides the neurosonological examination with ultrasound
tudy of the cerebroafferent vessels and of the intracranial
rteries by TCCS, all patients underwent brain MRI and MRA
nd DSA and blood sampling and other investigations for dif-
erential diagnosis of immunological or infectious etiology.
Diagnosis was made according to the approved criteria
Research Committee on Spontaneous Occlusion of the Circle
f Willis (moyamoya disease) in Japan] [7].
TCCS was performed as a basal evaluation and with con-
rast agents for the evaluation of intracranial vessels in
ower Modulation or Pulse Inversion. Ultrasound perfusional
tudy was also performed but the data were not analyzed,
ecause of the bilateral involvement in most patients and
he lesser reliability of PCA territory for a comparison, due
o the collateral circulation.
MRI and DSA were analyzed according to the Ministry of
ealth and Wellness of Japan criteria [7].
The mean follow-up was 1.8 years and it was both clin-
cal and neurosonological—neuroradiological (with MRI). All
atients were followed-up in at least 3 control visits, at
months from the diagnosis, at 6 months and at 12—18
onths.
esults
he main features of the six patients are illustrated in
able 1.
All patients had a bilateral involvement in the intracra-
ial circulation and all but one had a diagnosis of moyamoya
isease/phenomenon, because of the absence of the well-
nown risk factors and associated conditions; one patient
ad a unilateral involvement, and therefore the diagnosis
as a moyamoya syndrome. There is an evident prevalence
f the female sex (female to male ratio 5). TCCS study
as performed by an experienced neurosonologist both
ithout and with ultrasound contrast agents (SonoVue®) in
ll patients and no side effects from the procedure were
eported.
Neuroradiological examination, ﬁrst brain MRI and
ntracranial MRA, and second DSA, were performed because
f the suspicion of moyamoya arteriopathy and conﬁrmed
t. There was not any brain tissue abnormality suggesting
cute cerebrovascular event in all examined patients, nor
n basal MRI study and in control examinations. Both neu-
osonological ﬁndings and MRI ﬁndings did not change in
he follow-up examination, therefore a control DSA was not
erformed.
TCCS studies were analyzed mainly considering the
oppler waveform, because of the existing classiﬁcation of
he MCA ﬂow patterns (see Appendix A), made to classify
CD ﬁndings [8]. All patients with bilateral involvement but
ne had the same ﬂow pattern in the MC A on both sides and
similar situation was reported for the DSA classiﬁcation [9]
see Appendix B) but not in the same patients.
Both neurosonological and MRA ﬁndings were unchangedeurological events of vascular origin during the follow-up.
In Fig. 1 it is showed an example of the ﬁndings from the
hree techniques (TCCS, MRA, DSA) in two patients of our
eries.
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Table 1 Main features of followed-up patients.
Subjects Sexa Age at the
diagnosis
(years)
Affected
side
TCCS right
sideb
TCCS left
sideb
DSA stage
right sidec
DSA stage
left sidec
Cerebrovascular
events
Length of
follow-up
(years)
1 F 18 Left — High—high
ﬂow pattern
— Stage 4 None 4
2 F 41 Both High—low
ﬂow pattern
High—low
ﬂow pattern
Stage 3 Stage 3 None 2
3 F 31 Both High—high
ﬂow pattern
High—high
ﬂow pattern
Stage 3 Stage 3 None 1
4 F 28 Both High—low
ﬂow pattern
High—low
ﬂow pattern
Stage 4 Stage 4 None 3
5 F 25 Both High—low
ﬂow pattern
High—low
ﬂow pattern
Stage 3 Stage 3 None 2
6 M 32 Both High—low
ﬂow pattern
High—low
ﬂow pattern
Stage 4 Stage 5 None 2
a F is for female sex and M is for male sex.
b etail
iled i
a
t
c
p
p
(
m
cTCCS data were presented according to the ﬂow patterns d
classiﬁcation.
c TCCS data were presented according to the ﬂow patterns deta
Discussion
For the reasons detailed in the introduction, there are few
data about the natural course of the moyamoya disease in
asymptomatic patients, mainly in adult people, both in Asian
and particularly in European population. The lack of reli-
able informations is even more evident for asymptomatic
patients, particularly for the adult form of the disease,
because the introduction of noninvasive diagnostic tools
made possible the sporadical identiﬁcation of asymptomatic
subjects. In a Japanese questionnaire survey, made in 88
neurosurgical institutes in 1994, to deﬁne clinical features
t
t
a
Figure 1 Example of diagnostic results for two patients of our se
low ﬂow condition is illustrated; in the row ‘b’ a patient with low loed in Appendix A; only Doppler waveforms were used for this
n Appendix B.
nd outcome of asymptomatic moyamoya disease [10], only
hirty three asymptomatic moyamoya disease patients were
ollected (11 male, 22 female) and divided into 2 groups:
atients without any symptoms (group 1, mainly adult peo-
le), and patients without any symptoms except headache
group 2). In this survey the natural course of asymptomatic
oyamoya disease seemed benign and the need of a dedi-
ated prospective study about this item was proposed.But in the next years the non-invasive screening led
o a change in the known epidemiological data, also in
he Japanese population, as shown in a more recent
ll-inclusive survey of moyamoya disease in Hokkaido island
ries (1 TCCS, 2 MRA, 3 DSA). In the row ‘a’ patients with high
w ﬂow condition is showed.
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population 5.63 million) [11], that analyzed data from
67 newly registered patients with moyamoya disease from
002 to 2006. Overall the prevalence of the disease and the
ge at onset were reported higher than those previously
nown. The highest peak of onset age was older than those
eported previously. In addition, 17.8% of patients were
symptomatic at onset in all decades.
In European population the moyamoya disease has also
lesser prevalence, therefore large epidemiological data
re lacking, mainly about asymptomatic people. The lim-
ted existing European studies mostly deal with a mixed
ohort of MMD and angiographic syndromes caused by other
onditions, as in Khan’s study [12] about surgical revascu-
arization (15 of 23 patients with moyamoya angiopathy had
diopathic moyamoya disease). One of the largest European
ohort was recently published, but all 21 adult patients
ere symptomatic for ischemic cerebrovascular events at
he time of diagnosis [13]. There are few data in the litera-
ure also about the natural course of the disease in the white
merican population, and mainly in symptomatic people. In
retrospective study about the moyamoya phenomenon in
hese adult population, by review of angiographic records,
nly 3 of 34 patients were asymptomatic [14]. It is interest-
ng to note that these three patients were free of events at
he follow-up (5—8 years), but in symptomatic patients the
ecurrences of ischemic and hemorrhagic events was very
igh with the medical treatment.
onclusions
oyamoya disease is a condition lesser rare than otherwise
hought, and it is present also in adult caucasian people with
oth symptomatic and asymptomatic form. The subgroup of
symptomatic adult caucasian people is very small in the
iterature, because the diagnostic suspicion is casual, there-
ore few informations are available on the natural course of
his disorder. The smallest series in the literature raised the
uestion about the especially benign course of this form and
ur series seems to conﬁrm this impression.
ppendix A. Transcranial Doppler evaluation
akase et al. [8] classiﬁed the CBF velocity patterns into 3
ypes:
) the high—high ﬂow pattern, commonly seen in younger
patients, in whom high ﬂow velocities exist with high
ﬂow, but with moderate grade stenosis in the ICA or MCA,
in the absence of proper collateralization;
) the high—low ﬂow pattern, in which higher-grade
stenoses are associated with high velocity but lower over-
all ﬂow;
) the low—low ﬂow pattern, in which velocity and ﬂow are
low secondary to the highest degree of stenosis.
ppendix B. DSAuzuki and Takaku [9] have described 6 stages of moyamoya
rogression:
) narrowing of the CA termination;
[G. Malferrari et al.
) dilation of the proximal portions of the ACA and MCA with
initial basal moyamoya blush;
) proximal portions of the ACA and MCA are no longer visu-
alized; distal branches are still present due to collateral
vessels from the PCA and intensiﬁcation of themoyamoya
blush;
) minimization of the basal moyamoya network together
with progressive occlusion of the ICA, which reaches the
origin of the PCA;
) further reduction of moyamoya vessels, with complete
disappearance of the main arteries arising from the CA,
continuous decrease of moyamoya collateral vessels that
are more limited to the siphon area, and increased col-
lateral supply from the ECA; and
) disappearance of the moyamoya blush together with the
blood supply from the ICA.
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